ObvioHealth alternatives for 2026
ObvioHealth bundles software with a virtual CRO. If you want software on its own, priced for a sponsor or research team rather than an outsourced CRO engagement, WeGuide gives you eCOA, eConsent, wearables, and a whitelabel participant app, TGA certified and ISO 27001.
No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours.
.png)
Used by leading research and medical institutes.
%201.avif)
Why research teams look for an ObvioHealth alternative
ObvioHealth is strong in its lane. The smartphone-first BYOD model, the consumer health category experience, and the ObvioGo app are all genuine strengths. Teams look elsewhere for three reasons, and they're worth naming honestly.
The services plus technology bundle isn't always what sponsors want. ObvioHealth operates as a virtual CRO. Many engagements come with services delivery baked in: study design, operational run, patient recruitment support, regulatory submissions. For sponsors that already have their own CRO relationships, or teams that want to own study operations in-house, the bundled model adds cost and complexity that isn't always useful. WeGuide is a pure technology platform with no CRO services component, so sponsors and CROs keep ownership of how the study is run.
Nutraceutical and consumer health specialisation isn't a match for every study. ObvioHealth's case study portfolio leans heavily toward OTC, consumer health, and nutraceutical trials. That focus is genuinely useful if you're running those categories. For traditional Phase II/III clinical trials, paediatric studies, rare disease registries, population health cohorts, or employee wellbeing programmes, the specialisation becomes a constraint rather than an advantage.
The ObvioGo app carries ObvioHealth's brand. Participants download an ObvioGo app for ObvioHealth studies. For sponsor-branded patient engagement programmes, academic research, or registries where the participant relationship belongs to the research organisation and not the platform vendor, a whitelabel app under your own brand changes the participant experience significantly.
WeGuide takes a different approach. Pure technology, no CRO services attached, whitelabel apps under your brand, and use-case coverage that extends well beyond DCT into registries, wellbeing, and population health. The two models serve different studies, and on this page we'll tell you honestly which is which.
%20(1).png)
Key differences between WeGuide and ObvioHealth
For teams that have already evaluated ObvioHealth, here's what changes when you move to WeGuide.
.png)
Whitelabel mobile apps under your brand
.png)
Technology without a bundled CRO engagement
.png)
Broader use case coverage beyond DCT
Full comparison: WeGuide vs ObvioHealth
.png)
Top alternatives to ObvioHealth in 2026
Here's the shortlist of platforms most teams evaluate alongside ObvioHealth, whether they're looking for a pure technology platform, a broader use-case fit, or a different pricing model.
.png){kind=small}
.png){kind=small}
All-in-one platform
WeGuide combines eCOA, eConsent, data collection, and telehealth in a single platform with whitelabel apps under your own brand.
.png){kind=icon}
eConsent
.png)
.png){kind=icon}
Screening
.svg)
.svg)
.png){kind=icon}
Data collection
.svg)
.png){kind=icon}
Telehealth
.png)
.png)
.png)
%20(1)%20(1)%20(1).png)
%20(1).png)
.png)
.png)
Continuous engagement, not once-off surveys
Push notifications, educational content delivery, gamification, and a study companion that guides participants through the protocol. This is the difference between collecting data when a participant remembers and collecting data on schedule because the app is genuinely useful to them. The BRACE Trial achieved 90% adherence across 6,000 participants in five countries using this architecture. See WeGuide’s patient education module →
Push notifications and reminders
Study companion
Educational content and gamification
Mobile multimodal collection
Capture the full picture of a participant's experience through forms, video, pathology, and passive sensor data all in the same app.
Forms
.svg){kind=icon}
Video
.svg){kind=icon}
Pathology
.svg){kind=icon}
Sensors
.png)
%20(1).png)
.png)
%20(1).png)
.png)
%20(1).png)
.png)
Whitelabel: your study, your brand
WeGuide ships native iOS and Android apps fully branded under your organisation's name and identity. The app becomes the study's home for the participant, which is a big part of why our studies average 94% adherence.
.svg){kind=icon}
Your brand end-to-end
.svg){kind=icon}
App store distribution
.svg){kind=icon}
Multilingual out of the box.
Where WeGuide goes further
For teams that need the clinical layer without the rest of the Vault platform, here's what changes when you move from Veeva Clinical to WeGuide.
.svg)
Broader use-case coverage
.svg)
Whitelabel mobile apps under your brand
Technology without a bundled CRO engagement
Patient registry as a first-class use case
Employee wellbeing, population health, and citizen science
No-code programme builder for research teams
200+ validated instrument library
.png)
Australian data residency and TGA certification
.svg)
Integrated eConsent, telehealth, and analytics in the core licence
Built for regulated research
Every WeGuide study runs on our managed infrastructure. Your IT team doesn't patch servers, manage backups, or run disaster recovery drills.
.png){kind=small}
TGA Certified
.png){kind=small}
ISO 27001
.png){kind=small}
Data Hosted in Australia
.png){kind=small}
GDPR Compliant
Biometric Security
.png){kind=small}
256-bit AES Encryption
Faster
Your own platform ready in weeks and changes are made in minutes
Adherence Rates
High patient engagement and better quality data
Cost Saving
Reduce financial and technology risk when creating a secure health app
Patients Impacted
With our ease of use and roll out, our apps have engaged 200k+ users
Where ObvioHealth genuinely excels
Nutraceutical, OTC, and consumer health category experience. ObvioHealth has run hundreds of studies in nutraceutical and consumer health categories. That case study portfolio is a genuine asset for sponsors working in those areas. Regulatory context, study design experience, and recruitment know-how specific to nutraceutical trials are harder to replicate than any platform feature.
Smartphone-first BYOD model. ObvioGo was built for smartphone delivery from day one, which shows in the participant experience. The BYOD architecture, participant onboarding flow, and everyday usability are solid. WeGuide is also BYOD-first, so this is common ground rather than a differentiator.
Virtual CRO operational capability. If you want a partner who will design, run, and deliver a study alongside providing the technology, ObvioHealth can do that. WeGuide cannot. We're a platform, not a CRO, and for sponsors who want services delivery bundled with the technology, ObvioHealth is a genuinely different offer.
Content-led SEO and category thought leadership. ObvioHealth ranks #1 in Google for "hybrid clinical trials", "remote monitoring in clinical trials", and "virtual clinical trials". The educational content on their resources hub is well-written and category-relevant. If you're researching DCT concepts, their articles are worth reading.
ObvioGo platform maturity for ePRO and remote monitoring. The ObvioGo app is mature, well-designed, and battle-tested across real studies. Nothing about ObvioHealth's technology is a weakness. What changes between platforms is fit to use case, not technical competence.
If your study sits inside ObvioHealth's nutraceutical or consumer health wheelhouse and you want a bundled virtual CRO engagement, they're a strong choice and we'll say so upfront.
WeGuide and existing CRO partners
WeGuide is a technology platform. If you already have a CRO relationship and want to add a participant-facing platform under your sponsor brand, WeGuide runs alongside your CRO's operational delivery. The platform sits where the participant does: on their phone, under your brand, collecting the data your study needs. Your CRO keeps running the study. Many of our sponsor customers work this way.
How the switch works
For teams that are evaluating ObvioHealth, or already running an ObvioHealth study and considering a platform change, here's how onboarding typically plays out with WeGuide.
Discovery Call
A 30-minute conversation with one of our research delivery team. We look at your protocol, your use case, and whether WeGuide is actually the right fit. If your study needs a virtual CRO services engagement, we'll tell you WeGuide isn't that and point you back toward ObvioHealth or Curebase.
Study Configuration
Our team works alongside yours to configure the study in WeGuide. Typical timeline: two to four weeks. Your research coordinators, not a services team, own the configuration.
.svg)
Participant Onboarding
The whitelabel app goes live under your brand. Participants download the app, complete eConsent, and begin the study. eCOA instruments, engagement templates, wearable data collection, and telehealth visits are all live from day one.
Ongoing Support
You get a named research delivery contact, not a ticketing queue. We stay involved for the life of the study.
.png)
.png)
.png)
.png)
Case studies: research teams running engagement-led studies beyond DCT
BRACE Trial (Murdoch Children's Research Institute)
Murdoch Children's Research Institute. A global randomised controlled trial studying whether the BCG vaccine could reduce COVID-19 symptom severity. Launched across five countries with 6,000+ participants in six weeks during the pandemic. Adherence exceeded 90%. The kind of clinical trial delivery that sits outside ObvioHealth's nutraceutical and consumer health focus.
GenV (Generation Victoria)
A population health registry tracking more than 100,000 Victorian families from birth. Longitudinal data collection, multi-year participant relationships, and a family-branded whitelabel app. Registry work that ObvioHealth doesn't offer.
INHERIT
A rare disease patient registry for facioscapulohumeral muscular dystrophy, running globally with longitudinal participant engagement. Another registry use case outside ObvioHealth's scope.
%201.avif)
Questions
Straight answers on how WeGuide compares to ObvioHealth, what migration looks like, and when ObvioHealth is the right call.
Contact usIs WeGuide a full replacement for ObvioHealth?
It depends on what you're buying. For nutraceutical and consumer health DCTs where ObvioHealth's category experience genuinely matters, and where you want a virtual CRO delivering services alongside the technology, ObvioHealth has specialisation that WeGuide doesn't replicate. For broader use cases, clinical trials outside those categories, patient registries, employee wellbeing, and population health, or for sponsors who want a pure technology platform without a bundled CRO engagement, WeGuide is the right choice. The clearest way to answer the question is a discovery call where we look at your study together.
Does WeGuide support nutraceutical and consumer health trials?
Yes, with ePRO, eConsent, wearables, telehealth, and a library of 200+ validated instruments. The platform covers the protocol requirements of nutraceutical and consumer health studies cleanly. What we don't have is ObvioHealth's specific nutraceutical case study portfolio, so if you're looking for a partner who has already run dozens of studies in your exact sub-category, that's worth weighing. For the underlying technology needs, WeGuide delivers.
Can WeGuide integrate with ObvioHealth's ObvioGo?
Yes, via the Integration Engine, typically through data export and API integration. For sponsors who want to move data out of ObvioGo or run both platforms side by side, integration is supported as part of standard configuration.
How does pricing compare?
ObvioHealth typically bundles virtual CRO services with the platform, so a quote includes services delivery alongside technology. WeGuide is technology only and project based, with every module included in the core licence. The commercial comparison isn't a straight platform-to-platform number because ObvioHealth is often selling a larger scope. For sponsors who already have CRO services covered elsewhere, the WeGuide commercial model is typically significantly more accessible.
Does WeGuide have smartphone first BYOD like ObvioHealth?
Yes. WeGuide is BYOD first, with participants using their own iOS and Android phones through a whitelabel app under your organisation's brand. Native Apple Health, Google Fit, and Garmin integration runs on the same devices. On device model, WeGuide and ObvioHealth are aligned. The differences sit in branding, use-case coverage, and the services versus technology only commercial model.
Can we migrate from ObvioHealth to WeGuide mid study?
Possible, and a few teams have done it. Data migration happens through the Integration Engine, typical transition timeline is four to six weeks for configuration plus data migration, and participant re onboarding to the new whitelabel app is the most sensitive piece. For mid-study transitions, we plan the migration carefully alongside your ethics committee and participant communications workflow.
Compare WeGuide to other clinical trial platforms
Eleven more honest platform comparisons, from academic EDC to enterprise pharma.
.png){kind=small}
Veeva Vault Clinical
Life sciences cloud
Thread Research
Virtual CRO + software
Clario
eCOA specialist
Oracle Clinical
Clinical One & InForm
.png){kind=small}
OpenClinica
Open-source EDC
.png){kind=small}
Medable
DCT for top-50 pharma
.png){kind=small}
IQVIA
Full-service CRO
Florence Healthcare
Site-side workflow
Science 37
Open-source EDC
obviohealth
Virtual site service
Medidata Rave
Enterprise pharma stack
REDCap
Data Collection
Never miss an update
Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.
By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.
Certified and Compliant by Leading Standards
